Reporter

Vanderbilt-Ingram Cancer Center researchers included in ASCO annual report

Two researchers from Vanderbilt-Ingram Cancer Center (VICC) are featured in Clinical Cancer Advances 2020: ASCO’s Annual Report on Progress Against Cancer.

Five things to know about China’s coronavirus outbreak

Vanderbilt infectious diseases specialist Thomas Talbot, MD, MPH, answers questions about the current novel coronavirus outbreak in China.

Vanderbilt-Ingram Cancer Center patient first for new cell engineering platform

Rhea Dodd is the first patient treated with an experimental cancer vaccine derived from a completely new cell engineering platform.

Vials with medication and syringe on blue methacrylate table. Horizontal composition. Top elevated view.

Vaccine Program receives NIH renewal of VTEU

The Vanderbilt Vaccine Research Program has received a grant from the NIH to continue its work as one of the nation’s nine Vaccine and Treatment Evaluation Units.

Study tracks causes of high antibiotic prescribing rates in Tennessee

For a few years, Tennessee has been ranked as one of the highest antibiotic prescribing states in the nation, and a recent study showing that fewer than 2% of clinicians were responsible for prescribing 25% of pediatric antibiotics is moving some to action.

Vanderbilt Health to be featured on local portion of Super Bowl broadcast

Nashville area television viewers will see Vanderbilt Health featured during Sunday’s Super Bowl.

1 208 209 210 211 212 725